US-based privately held genomics technology company CS Genetics announced on Thursday that it has named Jay Harger, PhD as its new chief operating officer and Mike Stubbington, PhD as its new chief scientific officer.
In the new role, Harger will be responsible for heading the firm's global operations strategy, to include facilities, manufacturing, supply chain, and program management. He originally joined CS as senior vice president of Operations. He has also served at Illumina for more than 15 years and worked in various senior leadership roles, including senior director of Product Management and senior director of Portfolio Management.
In the new role, Stubbington will be responsible for heading the company's global research and development group. He will also work as site head for the company's UK operations based in Cambridge. He originally joined CS as vice president of Research and Development. He has served in companies such as 10x Genomics and at Wellcome Sanger Institute.
TFF Pharmaceuticals partners on dry powder inhaled mRNA treatment
Merck's GARDASIL 9 shows promise in preventing HPV infection in Japanese males
Solu Therapeutics names new chief medical officer
Arecor reports positive Phase I Results for AT278 insulin at EASD 2024
Dupixent shows promise in treating chronic spontaneous urticaria
Carisma and Moderna expand collaboration
Active Biotech reports promising results for laquinimod eye drops
Phanes Therapeutics doses first subject in clinical study of PT886 in combination with chemotherapy
Eli Lilly and Company names new EVP and CFO
AbbVie advances solid tumour pipeline with new data at ESMO 2024
Amgen showcases promising data for IMDELLTRA in small cell lung cancer at WCLC 2024
Terns Pharmaceuticals reports positive Phase 1 data for TERN-601
Diamyd Medical seeks Fast-Track approval for Type 1 Diabetes immunotherapy